SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark Wise who started this subject3/17/2002 4:41:38 PM
From: mistermj  Read Replies (2) of 2135
 
Endostatin CI trials and "Remarkable Results"
One of these days this company is going to do an "ENMD" again....(gg)
"Cooke said he recently interviewed 2 patients who have been on ES for quite a long time on CI pumps. The results are remarkable, both living normal lives without side effects, tumors shrinking very very slowly. One is the Boston doctor with islet cell pancreatic cancer. The other is a man in AZ with liposarcoma. Both patients had mets to liver and elsewhere. Both had been told to go home, we have nothing else to offer. Today, with ES, both are fine and under daily treatment. Two groups in Netherlands have similarly interesting results, but Cook doesn't have more information because the manufacturer is being very cautious with data to avoid false hopes".
ragingbull.lycos.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News